Literature DB >> 15770097

A case-control study for multidrug-resistant tuberculosis: risk factors in four European countries.

M Casal1, M Vaquero, H Rinder, E Tortoli, J Grosset, S Rüsch-Gerdes, J Gutiérrez, V Jarlier.   

Abstract

The aim of this study was to detect risk factors for multidrug resistance in patients with pulmonary tuberculosis in four European Union countries: France, Germany, Italy, and Spain. A prospective epidemiological case control study was conducted, made up of patients with clinically diagnosed and microbiologically confirmed pulmonary tuberculosis in the four countries between 1997 and 2000. A total of 138 cases and 276 controls were studied. Considering the four countries as a whole, the most statistically significant risk factors were as follows: intravenous drug use (OR 4.68); asylum-seeker support (OR 2.55) as income factor; living in a nursing home (OR 2.05); previous tuberculosis (OR 2.03) with pulmonary location; prison (OR 2.02); known tuberculosis contacts (OR 2.01); immunosuppression other than human immunodeficiency virus (HIV) (OR 1.96); acquired immunodeficiency syndrome (AIDS) (OR 1.96); current tuberculosis with pulmonary location (OR 1.77); and health-care worker (OR 1.69). These risk factors will have to be taken into account in the European Union as a whole, as well as in each individual country, to establish a health policy of monitoring and control for these cases of multidrug resistance. Although rare, their seriousness makes them particularly important.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15770097     DOI: 10.1089/mdr.2005.11.62

Source DB:  PubMed          Journal:  Microb Drug Resist        ISSN: 1076-6294            Impact factor:   3.431


  25 in total

1.  Synthesis of a series of novel 2,5-disubstituted-1,3,4-oxadiazole derivatives as potential antioxidant and antibacterial agents.

Authors:  M Aruna Sindhe; Yadav D Bodke; R Kenchappa; Sandeep Telkar; A Chandrashekar
Journal:  J Chem Biol       Date:  2016-07-07

2.  Factors associated with low cure rate of tuberculosis in remote poor areas of Shaanxi Province, China: a case control study.

Authors:  Xianqin Ai; Ke Men; Liujia Guo; Tianhua Zhang; Yan Zhao; Xiaolu Sun; Hongwei Zhang; Guangxue He; Marieke J van der Werf; Susan van den Hof
Journal:  BMC Public Health       Date:  2010-03-07       Impact factor: 3.295

3.  Risk factors for multidrug resistant tuberculosis patients in Amhara National Regional State.

Authors:  Wondemagegn Mulu; Daniel Mekonnen; Mulat Yimer; Aschalew Admassu; Bayeh Abera
Journal:  Afr Health Sci       Date:  2015-06       Impact factor: 0.927

4.  Clinical prediction rule for stratifying risk of pulmonary multidrug-resistant tuberculosis.

Authors:  Dalila Martínez; Gustavo Heudebert; Carlos Seas; German Henostroza; Martin Rodriguez; Carlos Zamudio; Robert M Centor; Cesar Herrera; Eduardo Gotuzzo; Carlos Estrada
Journal:  PLoS One       Date:  2010-08-11       Impact factor: 3.240

5.  Drug-susceptibility patterns of Mycobacterium tuberculosis in Mpumalanga province, South Africa: possible guiding design of retreatment regimen.

Authors:  E Green; C L Obi; M Nchabeleng; B E de Villiers; P P Sein; T Letsoalo; A A Hoosen; P O Bessong; R N Ndip
Journal:  J Health Popul Nutr       Date:  2010-02       Impact factor: 2.000

6.  A close-up on the epidemiology and transmission of multidrug-resistant tuberculosis in Poland.

Authors:  T Jagielski; A Brzostek; A van Belkum; J Dziadek; E Augustynowicz-Kopeć; Z Zwolska
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-07-20       Impact factor: 3.267

7.  Risk factors for multidrug-resistant tuberculosis in a tuberculosis unit in Madrid, Spain.

Authors:  I Suárez-García; A Rodríguez-Blanco; J L Vidal-Pérez; M A García-Viejo; M J Jaras-Hernández; O López; A Noguerado-Asensio
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-10-02       Impact factor: 3.267

8.  First national survey of anti-tuberculosis drug resistance in Azerbaijan and risk factors analysis.

Authors:  N Alikhanova; I Akhundova; M Seyfaddinova; E Mammadbayov; V Mirtskulava; S Rüsch-Gerdes; R Bayramov; J Suleymanova; K Kremer; A Dadu; C D Acosta; A D Harries; M Dara
Journal:  Public Health Action       Date:  2014-10-21

9.  Characteristics of multidrug-resistant tuberculosis in Namibia.

Authors:  Philip M Ricks; Farai Mavhunga; Surbhi Modi; Rosalia Indongo; Abbas Zezai; Lauren A Lambert; Nick DeLuca; Jamie S Krashin; Allyn K Nakashima; Timothy H Holtz
Journal:  BMC Infect Dis       Date:  2012-12-29       Impact factor: 3.090

10.  Factors Associated with Multi-Drug Resistant Tuberculosis among TB Patients in Selected Treatment Centers of Amhara Region: A Case-Control Study.

Authors:  Getahun Yeshiwas Ambaye; Gebiyaw Wudie Tsegaye
Journal:  Ethiop J Health Sci       Date:  2021-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.